PLX - Protalix BioTherapeutics Inc.
2.12
-0.030 -1.415%
Share volume: 722,028
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$2.15
-0.03
-0.01%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 11-14-2024 | 03-17-2025 | 05-09-2025 | 08-14-2025 | 11-13-2025 | 03-18-2026 | |
| Cash flow financing | -20.420 M | 3.626 M | 5.076 M | 4.104 M | 0.000 | 146.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 2.215 M | 153.000 K | 0.000 | 146.000 K | |
| Cash flow | 4.012 M | -7.703 M | -294.000 K | -1.567 M | 0.000 | 1.064 M | |
| Net income | 3.236 M | 6.494 M | -3.619 M | 164.000 K | 2.355 M | -5.504 M | |
| Depreciation | 329.000 K | 334.000 K | 346.000 K | 360.000 K | 372.000 K | 387.000 K | |
| Changes in inventories | 0.000 | 0.000 | -1.737 M | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 20.327 M | -15.320 M | -312.000 K | -438.000 K | -504.000 K | -1.112 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 20.411 M | -14.895 M | -6.000 K | -7.000 K | -6.000 K | -709.000 K | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 87.000 K | 425.000 K | 306.000 K | 431.000 K | 498.000 K | 403.000 K | |
| Cash Change | 4.010 M | -7.649 M | -302.000 K | -1.563 M | -4.248 M | 1.033 M |